Trademarkia Logo

Canada

C$
ALTAVANT LOGO
REGISTERED

on 1 Nov 2022

Last Applicant/ Owned by

ALTAVANT SCIENCES GMBH

Viaduktstrasse 84051 Basel

CH

Serial Number

1951296 filed on 13th Mar 2019

Registration Number

TMA1148583 registered on 1st Nov 2022

Registration expiry Date

1st Nov 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ALTAVANT LOGO

Trademark usage description

pharmaceutical preparations for human use for the treatment of pulmonary arterial hypertension, pulmonary fibrosis, sarcoidosis, and respiratory disea Read More

Vienna Information


26 . 3 . 1

One triangleUn triangle

26 . 3 . 11

Triangles containing one or more quadrilateralsTriangles contenant un ou plusieurs quadrilatères

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 3 . 26

Triangles with cutout areasTriangles avec des zones découpées

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 3

Letters or numerals forming any other quadrilateral (surface or periphery)Lettres ou chiffres formant un autre quadrilatère (surface ou pourtour)

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment of pulmonary arterial hypertension, pulmonary fibrosis, sarcoidosis, and respiratory diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of pulmonary arterial hypertension, pulmonary fibrosis,sarcoidosis, and respiratory diseases, disorders and conditions.


Classification kind code

11

Class [042]
Scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials.


Classification kind code

11

Class [044]
Providing health and medical information in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions.


Classification kind code

11

Mark Details


Serial Number

1951296

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 26th Oct 2022
Registration Pending
Submitted for opposition 191
on 26th Oct 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 3rd Aug 2022
Advertised
Submitted for opposition 26
on 15th Jun 2022
Approved
Submitted for opposition 27
on 15th Jun 2022
Approval Notice Sent
Submitted for opposition 22
on 6th Oct 2021
Search Recorded
Submitted for opposition 20
on 6th Oct 2021
Examiner's First Report
Submitted for opposition 31
on 18th Mar 2019
Formalized
Submitted for opposition 1
on 14th Mar 2019
Created
Submitted for opposition 30
on 13th Mar 2019
Filed